Live Breaking News & Updates on Dutch Melanoma Treatment Registry

Stay updated with breaking news from Dutch melanoma treatment registry. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Advanced melanoma survival rates improve significantly from 2013 to 2019, Dutch study finds

The change in overall survival (OS) among advanced melanoma patients diagnosed between 2013 and 2021. ....

United States , The Netherlands , American Joint Committee On Cancer , Cytotoxict Lymphocyte Antigen , Programmed Cell Death , Mitogen Activated Protein Kinase , Lymphocyte Activation Gene , Tumor Infiltrating Lymphocyte , Dutch Melanoma Treatment Registry , American Joint Committee , Brain Metastases , Ell Death , Ctla 4 , Programmed Cell Death ,

Suppressing Immune-Related Toxicity and Survival in Melanoma

Researchers found that second-line immunosuppression for severe immune-related adverse events was associated with impaired survival outcomes among patients with advanced melanoma. ....

New Jersey , United States , Shailender Bhatia , Carmana Giacomantonio , Andrew Pecora , Hackensack Meridian John Theurer Cancer Center , Fred Hutchinson Cancer Center , Celularity Inc , Dalhousie University , Dutch Melanoma Treatment Registry , Hackensack Meridian , John Theurer Cancer Center , Nova Scotia , Malignant Melanoma , Skin Cancer , Alignant Skin Neoplasm , Biologic Therapy , Malignant Kidney Neoplasm , Kidney Cancer , Renal Cell Cancer , Renal Cell Carcinoma , Ancer Kidney , Ancer Renal Cell , Alignant Neoplasia , Kidney Cancer , Adrenal Cancer ,

Zika vaccine candidate shows promise in phase I trial

URL goes live when the embargo lifts
The Zika virus candidate, Ad26.ZIKV.001, a replication-incompetent human adenovirus serotype 26 (ad26) vector showed promising safety and immunogenicity in a phase I clinical trial. Researchers say the vaccine warrants further development should the need reemerge. The findings are published in Annals of Internal Medicine.
Zika virus (ZIKV) infection is transmitted via mosquito or sexually and may cause severe congenital disease after maternal-fetal transmission. The incidence of Zika virus has declined since the 2015-2016 outbreak, but geographic expansion of the Aedes aegypti mosquito to areas where population-level immunity is low poses a substantial risk for future epidemics. Currently, no vaccine is available. ....

Ellen Kapiteijn , Nadinec Salisch , W Alton Russell , Angela Collom , Danh Barouch , Blood Products Advisory Committee , Leiden University Medical Center , Beth Israel Deaconess Medical Center , Stanford University , Janssen Vaccines , Credible Interval , Dutch Melanoma Treatment Registry , Endocarditis Associated , Illicit Drugs , Medicine Health , Clinical Trials , Environmental Health , Health Care Systems Services , Health Professionals , Infectious Emerging Diseases , Internal Medicine , டப்ல்யூ ஆல்டன் ரஸ்ஸல் , ஏஞ்சலா கோலம் , பெத் இஸ்ரேல் டேப்ககோணேஸ் மருத்துவ மையம் , ஸ்டான்போர்ட் பல்கலைக்கழகம் , ஜான்சன் தடுப்பு மருந்துகள் ,